By Joey Wong, Director of Investor Research, Hong Kong BD, LSN
Diagnostics are becoming a cornerstone of modern healthcare, driving earlier detection, more precise treatments, and improved patient outcomes. From cutting-edge sequencing technologies and liquid biopsies to AI-driven tools and digital platforms, diagnostics are shaping a more preventative and personalized future for medicine.
RESI Boston will feature a Diagnostics Panel. This 50-minute panel will bring together leading investors and strategic partners who focus on early-stage diagnostics innovation. Panelists will discuss what makes a diagnostic technology attractive from both a clinical and commercial perspective, how they evaluate regulatory and reimbursement potential, and the areas where they see the most pressing unmet needs. From seed-stage investors to growth-equity leaders, this year’s panel will feature a range of investment perspectives. With representation from venture capital, strategic investors, and international funds, attendees will gain a well-rounded view of the current diagnostics investment landscape.
For founders developing solutions in oncology, infectious disease, chronic conditions, or personalized medicine, this session offers actionable guidance on securing funding, gaining market traction, and building successful partnerships. Expect practical insights on differentiation, positioning, and scaling impactful innovations in a competitive and fast-evolving space.
 |
 |
 |
| John Tremblay Investor Launchpad Venture Group (Moderator) |
Navin Govind Partner Evidence Ventures |
Anula Jayasuriya Co-Founder and Partner Kidron Capital |
 |
 |
 |
| Chris Murray Principal MVM Life Science Partners |
Mike Thomas Managing Partner Bold Brain Capital |
Chensu Wang Investment Manager Yonjin Venture |
Don’t miss this opportunity to connect with investors and industry leaders shaping the future of diagnostics. Register now for RESI Boston this September and take the next step in advancing your diagnostic innovation.
Next Phase Newsletter 
Leave a comment